Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: evidence from cultured explants.
about
The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intakeDevelopmental origins of NAFLD: a womb with a clue.Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.Molecular pathways in non-alcoholic fatty liver disease.A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome.Endocannabinoid signaling at the periphery: 50 years after THC.Physiology and pathophysiology of liver lipid metabolism.Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes.Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.Mitochondria: a possible nexus for the regulation of energy homeostasis by the endocannabinoid system?Developmental programming of somatic growth, behavior and endocannabinoid metabolism by variation of early postnatal nutrition in a cross-fostering mouse model.Mechanisms underlying restoration of hepatic insulin sensitivity with CB1 antagonism in the obese dog model.Network analyses identify liver-specific targets for treating liver diseases.Identification of genetic loci associated with different responses to high-fat diet-induced obesity in C57BL/6N and C57BL/6J substrains.Overactivation of the endocannabinoid system alters the antilipolytic action of insulin in mouse adipose tissue.Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease.Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide
P2860
Q26850858-0541E73A-87B5-4E59-84E2-430BD0C7C373Q30241940-5E4BE59F-105C-4E26-A44F-59985497B45CQ33731729-AA770AA0-273A-462E-AEB9-33A5FF357C5AQ33890230-2B225910-69F1-4172-8B75-C943BA2A843FQ34926247-8B3DA675-713E-45A7-8744-4BDF95270A65Q35572176-7D846234-E492-4264-83FF-AE3E75E6BF2BQ35662655-A73E7FA3-7016-4B69-A32B-5AF13EC3B1B9Q36373581-31EA9F25-2D9F-45DD-BAD3-71D6F20F2CC3Q37581457-9DEADDA5-65EE-4E7B-81C4-2A8067084274Q38209755-8DB42557-2CF0-40EA-8608-9EB026570090Q38599770-26E09D8C-A64A-4209-932A-15B813BC9D3AQ40928899-9A43DC8E-35B6-4736-9EA7-EFD70EEA4DD0Q41526807-C9ACFB41-AB22-495A-A9FF-C32E51792BF7Q45850511-3F043048-A1A0-46C3-A9A8-E686E2A565BBQ51091657-A298FC3E-A382-4DAE-A0EE-041D5AB5AFA6Q51276156-B48A7574-1E80-4576-B43D-6118B02BFAEDQ57729876-1F8596B8-3CE9-4D02-BC6B-80CB794FAC99
P2860
Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: evidence from cultured explants.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antagonism of peripheral hepat ...... idence from cultured explants.
@en
type
label
Antagonism of peripheral hepat ...... idence from cultured explants.
@en
prefLabel
Antagonism of peripheral hepat ...... idence from cultured explants.
@en
P2093
P2860
P921
P356
P1433
P1476
Antagonism of peripheral hepat ...... idence from cultured explants.
@en
P2093
Bruno Vergès
Joseph Gresti
Laurent Demizieux
Louiza Djaouti
Pascal Degrace
P2860
P304
P356
10.1002/HEP.24733
P407
P50
P577
2012-01-30T00:00:00Z